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We read with interest the article by Robertson et al,1 which suggests radiotherapy 
should not be used to manage incompletely excised pleomorphic adenoma. 
 
The authors identify their follow up of 85 months as relatively short yet make firm 
recommendations. The first recurrence has been reported twenty years after initial 
treatment and facial palsy complicates up to a third of patients undergoing surgery, 
although it is frequently temporary.2-4 However, surgery in recurrence carries a higher 
risk of facial nerve injury,5 which is more likely to impact on the group who did not 
receive post-operative radiotherapy. Moreover, pleomorphic adenoma (PA) recurrence 
can involve the skull base or old scars making adequate salvage surgery difficult and 
often requiring loco-regional reconstruction adding a layer of complexity and surgical 
morbidity. This leaves a situation whereby a patient can conceivably have a 
combination of facial nerve sacrifice, residual disease and therefore the need for 
subsequent radiotherapy. Despite the inadequate follow-up in this study it is 
demonstrated radiotherapy does indeed lower crude recurrence rate.  
 
The functional implication of facial nerve sacrifice at any age is profound. It condemns 
patients to lifelong surgery to obtain eye protection and oral continence at the very 
least. Whilst techniques have evolved since the 1980s, rehabilitating patients with facial 
nerve loss is resource intensive, multi-stage and often socially disabling.  
 
Radiation techniques have also evolved significantly in recent decades.  With the advent 
of computer tomography (CT) planning and conformal delivery techniques, the volume 
treated has reduced compared to older series using field-based treatment.  Many 
patients now are treated with intensity modulated radiotherapy (IMRT).  With its highly 
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conformal dose distributions and relative skin sparing there is a further reduction in 
intermediate and high doses to the surrounding normal tissues.  This likely translates to 
a reduction in both acute (skin and mucosal) as well as late (functional and cosmetic) 
toxicity.  Radiotherapy following salvage may also require a larger volume to be treated 
than if it was delivered after initial surgery, particularly for those with multifocal 
recurrent disease.   
 
A good example of this is in a 34 year old male we treated who had recurrent PA in the 
right parotid bed 11 years after primary excision. The patient did not receive post-
operative radiotherapy. Salvage surgery mandated a radical parotidectomy and limited 
lateral temporal bone resection with cervicofacial rotation flap, and the facial nerve was 
reconstructed with a nerve to masseter transfer. Salvage surgery margins were close 
and so adjuvant radiotherapy was advised on the presumption that further failure at the 
skull base would be inoperable. This is not a unique case. 
 
We believe the authors allude to a bespoke multi-disciplinary (MDT) approach in these 
difficult cases where good data is still lacking, yet Robertson et al make firm 
recommendations regarding the utility of adjuvant radiotherapy. We do not advocate 
adjuvant radiotherapy for most patients after resection of PA. Strong consideration 
should be given to those with recurrent disease and those in the initial setting with 
residual (micro/macroscopic) disease, particularly if secondary surgery is likely to be a 
highly morbid procedure. We believe it may be better to inform patients about the 
likelihood of recurrence, the common side effects of radiation and the potential 
sequelae of salvage surgery in future years. It is our experience that many patients opt 
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for radiation treatment in order to avoid the disability of major facial/neck salvage 
surgery, in particular facial nerve sacrifice.  
 
It might be interesting to delineate the morbidity of salvage surgery in patients 
primarily irradiated versus those observed alone. It is likely that patients who were 
irradiated and still recur are a significant minority. Accurate data on this would further 
enhance the information available to patients treated by the MDT. 
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